ZA859315B - Novel,immunosuppressive compounds,a microbiological method for their preparation and their use as medicaments - Google Patents

Novel,immunosuppressive compounds,a microbiological method for their preparation and their use as medicaments

Info

Publication number
ZA859315B
ZA859315B ZA859315A ZA859315A ZA859315B ZA 859315 B ZA859315 B ZA 859315B ZA 859315 A ZA859315 A ZA 859315A ZA 859315 A ZA859315 A ZA 859315A ZA 859315 B ZA859315 B ZA 859315B
Authority
ZA
South Africa
Prior art keywords
plipastatin
medicaments
novel
preparation
ala
Prior art date
Application number
ZA859315A
Other languages
English (en)
Inventor
Hamao Umezawa
Takaaki Aoyagi
Tomio Takeuchi
Masa Hamada
Hiroshi Naganawa
Yasuhiko Muraoka
Takaaki Nishikiori
Original Assignee
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chem Res Found filed Critical Microbial Chem Res Found
Publication of ZA859315B publication Critical patent/ZA859315B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/085—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
ZA859315A 1984-12-06 1985-12-05 Novel,immunosuppressive compounds,a microbiological method for their preparation and their use as medicaments ZA859315B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59256475A JPS61134398A (ja) 1984-12-06 1984-12-06 新生理活性物質プリパスタチン及びその製造法

Publications (1)

Publication Number Publication Date
ZA859315B true ZA859315B (en) 1986-10-29

Family

ID=17293148

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859315A ZA859315B (en) 1984-12-06 1985-12-05 Novel,immunosuppressive compounds,a microbiological method for their preparation and their use as medicaments

Country Status (13)

Country Link
US (1) US4742155A (enExample)
EP (1) EP0192828B1 (enExample)
JP (1) JPS61134398A (enExample)
KR (1) KR920006881B1 (enExample)
AT (1) ATE63318T1 (enExample)
AU (1) AU583553B2 (enExample)
DE (1) DE3582791D1 (enExample)
DK (1) DK564785A (enExample)
ES (1) ES8701197A1 (enExample)
GR (1) GR852894B (enExample)
HU (1) HU193838B (enExample)
PT (1) PT81615B (enExample)
ZA (1) ZA859315B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217952A (en) * 1988-02-02 1993-06-08 Fujisawa Pharmaceutical Co., Ltd. Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
US5436140A (en) * 1988-02-02 1995-07-25 Fujisawa Pharmaceutical Co., Ltd. Process for producing WS-9326A and WS-9326B
IN167138B (enExample) * 1988-08-17 1990-09-01 Hoechst India
US5619066A (en) * 1990-05-15 1997-04-08 Dallas Semiconductor Corporation Memory for an electronic token
JPH07500814A (ja) * 1991-07-04 1995-01-26 ガーヴァン インスティチュート オブ メディカル リサーチ Ｐｌａ２阻害性化合物
CN1255143A (zh) * 1997-05-09 2000-05-31 阿格拉奎斯特公司 控制植物疾病和黄瓜十二星叶甲的芽孢杆菌新型菌株
CN117683074B (zh) * 2023-12-13 2024-08-16 山东绿邦生物科技有限公司 蜡样芽孢杆菌、蛋白酶抑制剂以及提高蛋白渣产量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201771A (en) * 1979-03-12 1980-05-06 Merck & Co., Inc. Antibiotic A43F

Also Published As

Publication number Publication date
PT81615B (pt) 1988-02-17
AU5030785A (en) 1986-06-12
HU193838B (en) 1987-12-28
HUT40707A (en) 1987-01-28
EP0192828B1 (en) 1991-05-08
GR852894B (enExample) 1986-04-01
EP0192828A3 (en) 1988-06-01
PT81615A (en) 1986-01-01
DK564785A (da) 1986-06-07
JPS61134398A (ja) 1986-06-21
KR860005027A (ko) 1986-07-16
ES8701197A1 (es) 1986-11-16
US4742155A (en) 1988-05-03
DK564785D0 (da) 1985-12-05
AU583553B2 (en) 1989-05-04
ATE63318T1 (de) 1991-05-15
EP0192828A2 (en) 1986-09-03
KR920006881B1 (ko) 1992-08-21
ES549565A0 (es) 1986-11-16
DE3582791D1 (de) 1991-06-13

Similar Documents

Publication Publication Date Title
GR851487B (enExample)
IE881269L (en) Steroids
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
ZA845940B (en) New compounds derived from diphenyl-methylene-ethylamine
PT81615A (en) Novel immunosupressive compounds a microbiological method for their preparation and their use as medicaments
ES8103071A1 (es) Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol
ZA856943B (en) 7-(2-dialkylamino)ethyl)-4-hydroxy-1,3-benzimidazol-2-ones
ES477167A1 (es) Un procedimiento para la preparacion de sales del acido (-)-lis-1,2,epoxipropilfosforico.
PT75385B (en) Process for the preparation of aminoglycosides derivatives and of compositions containing these derivatives
EP0387677A3 (en) Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation
Mazurkiewicz-Kilczewska Hexosamines and their biosynthesis in human amnion in vitro
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
DE3261643D1 (en) New peptide, process for preparation thereof and use thereof
PL247504A1 (en) Process for preparing novel 4-chlorophenoxyacetate